| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503589C Sulphona mide derivatives as prodrugs of aspartyl protease inhibitors |
| 06/24/2009 | CN100503566C Inhibitors of cytosolic phospholipase A2 |
| 06/23/2009 | USRE40793 treating conditions related to impairment of gastric emptying, gastromotility disorders; superior gastrokinetic properties; e.g. trans-4-amino-N-[(1-butyl-3-hydroxy-4-piperidinyl)methyl]-5-chloro-2,3-dihydro-7-benzofurancarboxamide |
| 06/23/2009 | US7550597 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/23/2009 | US7550595 Bronchodilators for treating chronic obstructive pulmonary disease or asthma; long duration of action; e.g. biphenyl-2-ylcarbamic acid 1-(2-([4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino)ethylpiperidin-4-yl ester; dosage forms such as metered dose inhalers |
| 06/23/2009 | US7550570 4,7-dichlororhodamine dyes labeled polynucleotides |
| 06/23/2009 | US7550503 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy |
| 06/23/2009 | US7550502 e.g. 5-[(R)-1-(4-tert-Butyl-phenyl)-5-oxo-pyrrolidin-2-ylmethoxy]-pentanoic acid; prostaglandin EP2 agonist; ocular hypotensive, antiinflammatory agent; glaucoma, inflammatory bowel disease and as presurgical adjuncts |
| 06/23/2009 | US7550499 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/23/2009 | US7550486 chemokine receptor (CCR) inhibitors for treating allergic or inflammatory diseases such as asthma or rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases; 2-((p-fluorobenzyl)piperidinylmethyl)cyclohexylureas of given formula |
| 06/23/2009 | US7550473 Pyrimidine derivatives useful as inhibitors of PKC-theta |
| 06/23/2009 | US7550460 2,4-pyrimidinediamine compounds and their uses |
| 06/23/2009 | US7550442 For therapy of subject infected with a retrovirus |
| 06/23/2009 | CA2398620C Pyrazine derivatives, pharmaceutical compositions containing them, and intermediates therefor |
| 06/23/2009 | CA2384354C Pyrimidine derivatives and herbicides containing them |
| 06/18/2009 | WO2009076571A1 Indole-substituted 3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | WO2009076142A2 Processes for producing cycloalkylcarboxiamido-pyridine benzoic acids |
| 06/18/2009 | WO2009075874A1 Gamma secretase modulators |
| 06/18/2009 | WO2009075277A1 4-aminopyrimidine derivative and medicinal composition containing the compound |
| 06/18/2009 | WO2009075250A1 Plant disease control agent |
| 06/18/2009 | WO2009074749A2 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
| 06/18/2009 | WO2009074593A1 Novel 2-pyrrolidinyl-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 06/18/2009 | WO2009074314A1 4-phenylpyrane-3,5-diones, 4-phenylthiopyrane-3,5-diones and 2-phenylcyclohexane-1,3,5-triones as herbicides |
| 06/18/2009 | WO2009074300A2 Hedgehog pathway antagonists and therapeutic applications thereof |
| 06/18/2009 | WO2009074019A1 Proteinase inhibitors useful for treating cancer |
| 06/18/2009 | WO2009016081A3 Benzoind0l-2-one derivatives for use in therapy |
| 06/18/2009 | WO2008072053A8 Substituted arylpyrazoles |
| 06/18/2009 | US20090158019 Computer Program Code Size Partitioning System for Multiple Memory Multi-Processing Systems |
| 06/18/2009 | US20090156831 Processes for preparing darifenacin hydrobromide |
| 06/18/2009 | US20090156801 Biomolecule labeling reactants based on azacycloalkanes and conjugates derived thereof |
| 06/18/2009 | US20090156642 5-Membered heterocyclic compound |
| 06/18/2009 | US20090156640 Nociceptin analogs |
| 06/18/2009 | US20090156622 2,4-pyrimidinediamine compounds and their uses |
| 06/18/2009 | US20090156608 Pyridazine Compound and Use Thereof |
| 06/18/2009 | US20090156601 kinase inhibitor; immunotherapy; viricides; function or behavior associated with PI3 kinase such as cancer, immune, cardiovascular, nervous system, metabolism/endocrine and neurological diseases, viral infection, inflammation; 2-(3-hydroxyphenyl)-4-(morpholin-4-yl)-6-(pyridin-3-ylmethylamino) pyrimidine |
| 06/18/2009 | US20090156589 1,2-di(cyclic group)substituted benzene derivative |
| 06/18/2009 | US20090156578 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents |
| 06/18/2009 | US20090156574 N-(4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl)-4-((4-oxopiperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agents |
| 06/18/2009 | US20090156571 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/18/2009 | US20090155203 Thrombopoietin mimetics |
| 06/18/2009 | CA2709288A1 Indole-substituted 3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | CA2709203A1 Hedgehog pathway antagonists and therapeutic applications thereof |
| 06/18/2009 | CA2708150A1 Fluorinated tripeptide hcv serine protease inhibitors |
| 06/18/2009 | CA2707598A1 4-phenylpyrane-3,5-diones, 4-phenylthiopyrane-3,5-diones and 2-phenylcyclohexane-1,3,5-triones as herbicides |
| 06/18/2009 | CA2707494A1 Processes for producing cycloalkylcarboxamido-pyridine benzoic acids |
| 06/18/2009 | CA2707492A1 Gamma secretase modulators |
| 06/18/2009 | CA2700559A1 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
| 06/17/2009 | EP2070934A1 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates |
| 06/17/2009 | EP2070922A1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors |
| 06/17/2009 | EP2070913A1 Ester derivatives as phosphodiesterase inhibitors |
| 06/17/2009 | EP2070534A2 Cyclopropyl and cyclobutyl epothilone analogs |
| 06/17/2009 | EP2069333A1 Pyrrole derivatives useful for the treatment of cytokine-mediated diseases |
| 06/17/2009 | EP2069332A2 Azetidine compounds as orexin receptor antagonists |
| 06/17/2009 | EP2069327A1 New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 06/17/2009 | EP2069316A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 06/17/2009 | EP2069313A2 Metalloprotease inhibitors |
| 06/17/2009 | EP2069305A2 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 06/17/2009 | EP2069303A2 Antiviral protease inhibitors |
| 06/17/2009 | EP2068632A1 Fungicides |
| 06/17/2009 | EP1789419B1 Gyrase inhibitors and uses thereof |
| 06/17/2009 | EP1611088B1 Hydroxamates as therapeutic agents |
| 06/17/2009 | EP1566384B1 Novel azole derivatives |
| 06/17/2009 | EP1542990B1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 06/17/2009 | EP1485375B1 Pyrimidine compounds |
| 06/17/2009 | EP1472230B1 Ansamycins having improved pharmacological and biological properties |
| 06/17/2009 | EP1337518B1 Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor |
| 06/17/2009 | EP1171428B1 Fab i inhibitors |
| 06/17/2009 | CN101460489A Modulators of ATP-binding cassette transporters |
| 06/17/2009 | CN101460488A 3',5'-di-o-acylated nucleosides for hcv treatment |
| 06/17/2009 | CN101460487A 3- (1, 3-benzodioxol-5-yl) -6- (4-cyclopropylpiperazin-1-yl)-pyridazine, its salts and solvates and its use as histamine H3 receptor antagonist |
| 06/17/2009 | CN100502087C 场致发光器件 Electroluminescent device |
| 06/17/2009 | CN100500662C Alkyl ether derivatives or salts thereof |
| 06/16/2009 | US7547794 antiproliferative agents; antiinflammatory agents; neurodegenerative agents; autoimmune diseases; viricides |
| 06/16/2009 | US7547782 Met kinase inhibitors |
| 06/16/2009 | US7547749 Triazine compounds, polymers comprising triazine structural units, and method |
| 06/16/2009 | US7547710 Such as (2E)-3-[3-(aminomethyl)-2-isobutyl-4-(4-methylphenyl)quinolin-6-yl]acrylamide; dipeptidyl peptidase IV inhibitors; diabetes, obesity, glucose intolerance |
| 06/16/2009 | US7547702 Glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents |
| 06/16/2009 | US7547696 Aminoquinoline derivatives and their use as adenosine A3 ligands |
| 06/16/2009 | US7547694 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions |
| 06/16/2009 | CA2574904C Antiretroviral enantiomeric nucleotide analogs |
| 06/16/2009 | CA2452217C Hiv inhibiting pyrimidines derivatives |
| 06/16/2009 | CA2451474C Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 06/16/2009 | CA2353063C Benzimidazole compounds that are vitronectin receptor antagonists |
| 06/11/2009 | WO2009073757A1 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
| 06/11/2009 | WO2009073203A1 Trp-m8 receptor ligands and their use in treatments |
| 06/11/2009 | WO2009072649A1 4-arylphenyl derivative |
| 06/11/2009 | WO2009071535A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation |
| 06/11/2009 | WO2009071509A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| 06/11/2009 | US20090149652 Affinity for somatostatin receptors; used for the treatment of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome; 4-(urea or thiourea substituted)-1-alkylpiperidines |
| 06/11/2009 | US20090149528 Cinnamic acid amides |
| 06/11/2009 | US20090149493 Inhibitors of the interaction between mdm2 and p53 |
| 06/11/2009 | US20090149474 tert-butyl 4-[(4-chlorobenzoyl)amino]-2-(dimethylamino)-1-phenyl-1H-imidazole-5-carboxylate, used for the treatment of gastrointestinal disorders such as gastroesophageal reflux, irritable bowel syndrome, dyspepsia, diarrhea and for the inhibition of transient lower esophageal sphincter relaxations |
| 06/11/2009 | US20090149463 Therapeutic agents |
| 06/11/2009 | US20090149460 New Compounds |
| 06/11/2009 | US20090149459 P38 inhibitors and methods of use thereof |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090148531 Rate-controlled particles |
| 06/11/2009 | CA2707653A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation |
| 06/11/2009 | CA2707651A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |